Best Allergy Medication for Adults
Intranasal corticosteroids (such as fluticasone, mometasone, or budesonide) are the single most effective first-line medication for typical allergic symptoms in adults. 1
Why Intranasal Corticosteroids Are Superior
Intranasal corticosteroids control all four cardinal symptoms of allergic rhinitis—sneezing, itching, rhinorrhea, and nasal congestion—more effectively than any other single medication class. 1 This represents a strong recommendation based on high-quality evidence from the Joint Task Force on Practice Parameters and the American Academy of Otolaryngology–Head and Neck Surgery. 1
The hierarchy of effectiveness is:
- Intranasal corticosteroids > intranasal antihistamines > oral antihistamines for overall symptom control 2
- Intranasal corticosteroids are particularly superior for nasal congestion, which oral antihistamines address poorly 3
When to Use Oral Antihistamines Instead
For mild intermittent symptoms only, second-generation oral antihistamines (cetirizine, fexofenadine, desloratadine, loratadine) or intranasal antihistamines (azelastine, olopatadine) are acceptable alternatives. 1, 3
Critical caveat: First-generation antihistamines (diphenhydramine, chlorpheniramine) should be avoided entirely due to significant sedation, cognitive impairment, and anticholinergic effects. 1, 4
When Monotherapy Fails: Escalation Strategy
If intranasal corticosteroid alone is inadequate, add an intranasal antihistamine—not an oral antihistamine. 1
- Adding oral antihistamines to intranasal corticosteroids provides no additional benefit and is strongly not recommended 1
- The fixed-dose combination spray (azelastine 548 mcg + fluticasone 200 mcg) achieves approximately 40% greater symptom reduction than either agent alone 2
- In clinical trials, total nasal symptom scores dropped from baseline ~19/24 to ~13.3/24 with combination therapy versus ~14/24 with fluticasone alone 2
- Dysgeusia (bad taste) occurs in 2–13% of users; somnolence in 0.4–1.1% 1
What NOT to Use First-Line
Montelukast (leukotriene receptor antagonist) should not be first-line therapy. 2, 1
- Intranasal corticosteroids are significantly more effective than montelukast for nasal symptom reduction 2
- Consider montelukast only if the patient refuses intranasal therapy or has concurrent mild persistent asthma 2, 1
Practical Implementation Tips
Proper technique matters:
- Instruct patients to aim the spray away from the nasal septum to reduce epistaxis and local irritation 1
- Daily continuous use is more effective than intermittent "as-needed" use 1
For severe congestion requiring rapid relief:
- Topical decongestants (oxymetazoline) can be added for ≤3 days only to prevent rebound congestion (rhinitis medicamentosa) 1
- Oral decongestants (pseudoephedrine) combined with antihistamines provide enhanced congestion relief but require blood pressure monitoring in hypertensive patients 1
Real-World Effectiveness Data
Mobile health data demonstrate that patients using intranasal corticosteroid + intranasal antihistamine combination required rescue medication on only 30–35% of days, compared to 45–60% of days for those using intranasal corticosteroid alone. 1
Disease-Modifying Option
Allergen-specific immunotherapy (subcutaneous or sublingual) is the only treatment that modifies disease course and should be considered for moderate-to-severe allergic rhinitis inadequately controlled by pharmacotherapy. 1 This can alter natural history, reduce long-term medication needs, and potentially prevent new sensitizations. 1